
Orforglipron is a prescription medicine. When used alongside a calorie-reduced diet and increased physical activity, it can help obese adults, as well as certain overweight adults with weight-related conditions, lose excess weight and maintain weight loss.
Orforglipron should not be used concurrently with other GLP‑1 receptor agonist medications.
The safety and efficacy of Orforglipron in pediatric patients have not yet been established.
Mechanism of Action of OrforglipronThe active ingredient in Orforglipron is orforglipron, which belongs to a class of medications known as GLP-1 receptor agonists. GLP-1 is a natur···【more】
Article source:Lucius LaosRelease date:2026-06-12Recommended:21
Indicated Population and Basic Positioning of OrforglipronOrforglipron is a prescription medication clearly indicated for adults with obesity, or for adults who are overweight but ···【more】
Article source:Lucius LaosRelease date:2026-06-11Recommended:37

Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address: No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com

Name: Lucius

Telegram name: Vira
No.:0085253923643
Telegram name: Vira
No.:0085253923643